Related Experiment Video
Updated: Aug 29, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death
Ralf Baumann1, Carmen Casaulta, Dagmar Simon
1Department of Pharmacology, University of Bern, Switzerland.
Abstract:
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine known to activate macrophages and T cells. In this study, we demonstrate that recombinant MIF delays apoptosis of neutrophils in vitro. MIF action is dose and time dependent as well as specific since it was abolished with a neutralizing anti-MIF antibody. MIF, like G-CSF, delayed cleavage of the proapoptotic members of the Bcl-2 family Bid and Bax in neutrophils, suggesting that MIF inhibits apoptosis pathways proximal to mitochondria activation. Indeed, MIF also prevented release of cytochrome c and Smac from the mitochondria and subsequent activation of the critical effector caspase-3 in these cells. Moreover, we observed increased MIF plasma levels in patients with cystic fibrosis, a heterogeneous recessive genetic disorder associated with bacterial infections and delayed neutrophil apoptosis. In conclusion, MIF is a survival cytokine for human neutrophils, a finding with potential pathologic relevance in infectious diseases.
Insights
Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that prevents neutrophil death. This finding suggests MIF plays a role in infectious diseases by prolonging neutrophil survival.
Area of Science:
- Immunology
- Cell Biology
- Molecular Medicine
Background:
- Macrophage migration inhibitory factor (MIF) is a known pro-inflammatory cytokine.
- MIF activates macrophages and T cells.
- Neutrophil apoptosis is crucial for resolving inflammation and preventing tissue damage.
Purpose of the Study:
- To investigate the effect of MIF on neutrophil apoptosis.
- To elucidate the molecular mechanisms by which MIF influences neutrophil survival.
- To explore the potential role of MIF in cystic fibrosis.
Main Methods:
- Recombinant MIF was used to treat human neutrophils in vitro.
- Western blotting was employed to assess the cleavage of Bcl-2 family proteins (Bid, Bax).
- Mitochondrial assays measured the release of cytochrome c and Smac.
- Caspase-3 activity was quantified.
- MIF plasma levels were measured in patients with cystic fibrosis.
Main Results:
- Recombinant MIF significantly delayed neutrophil apoptosis in a dose- and time-dependent manner.
- MIF inhibited the cleavage of proapoptotic proteins Bid and Bax.
- MIF prevented the release of cytochrome c and Smac from mitochondria.
- MIF suppressed caspase-3 activation.
- Elevated MIF plasma levels were observed in cystic fibrosis patients.
Conclusions:
- MIF acts as a survival factor for human neutrophils.
- MIF inhibits apoptosis through pathways involving mitochondria and caspase activation.
- Increased MIF levels in cystic fibrosis suggest a role in delayed neutrophil apoptosis in this disease.
- These findings have potential implications for managing infectious diseases.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
10:05Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
Published on: January 25, 2017
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway